IRD
IRD
US67577R1023
Opus Genetics, Inc.
Loading chart...
Pure Price Volatility Risk (Market Swings)

The business itself is financially solid (Financial Health 65/100, minimal insolvency risk). The high overall score (7/7) is driven primarily by extreme stock price swings (±75.4% p.a.) and steep historical drawdowns.

Volatility Risk

Transparent evaluation of price volatility (SRI), Beta, and historical drawdowns.

Volatility Risk Score
7/7 Very High
7 / 7 SRI Price Fluctuation & Beta

Very high volatility or fundamental risks. Significant loss potential; strictly for aggressive investors. Moves noticeably less than the broader market (0.6x).

Beta (Market Relation)
0.62x
Defensive
Volatility (5Y p.a.)
75.4% p.a.
5-Year Horizon
Max Drawdown (5Y)
-88.9%
5-Year Horizon
Sharpe Ratio
-0.02
Return / Risk
Speculative / High Risk: Score Basis:

Multi-Horizon Risk & Performance Matrix

Historical volatility, drawdowns, and risk-adjusted return across 1, 3, 5, and 10 years.

High Volatility
Timeframe
Volatility (p.a.)
Max Drawdown
Sharpe Ratio
Return (p.a.)
1 Year — — — +117.6%
3 Years 75.3% -79.4% 0.09 +9%
5 Years 75.4% -88.9% -0.02 +0.8%
10 Years 86.1% -99.8% -0.34 -26.8%

Automated Risk & Health Notes (Red Flags)

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (75.4% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -99.8% in the extended horizon.

Corporate Governance & ISS Scores

Shareholder rights, board structure and audit safety (Scale 1 = Low Risk, 10 = High Risk)
Overall Governance Risk
5 ISS Score: 5 / 10
Audit Risk
6 ISS Score: 6 / 10
Board Risk
3 ISS Score: 3 / 10
Short Ratio
2.79
ende